Genie Energy (NYSE:GNE) Stock, Quote.Headers.trade-ideas

Genie Energy

Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.

Earnings

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Trading Ideas

ETRN

The CNN Money Fear and Greed index remained in the &#34;Greed&#34; zone on Monday.

U.S. stocks closed mixed on Monday, with the S&amp;P 500 settling lower for the second straight session. All three major indices closed recorded losses last week, with the S&amp;P 500 falling 0.26% and the blue-chip Dow declining 0.93%.

Fear &amp; Greed Index Remains In &#39;Greed&#39; Zone Ahead Of Inflation Data; S&amp;P 500 Falls For 2nd Session

Eurozone

Commodities

Global

Intraday Update

ELTK

LXRX

VTYX

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning higher on Monday.

The Dow traded up 0.08% to 38,753.49 while the NASDAQ fell 0.20% to 16,052.34. The S&amp;P 500 also fell, dropping, 0.14% to 5,116.66.

Dow Turns Higher; GDS Holdings Shares Climb

Movers

ATXI

BALY

BIAF

BILI

BNED

CERO

EGOX

GRPH

IMRN

ITRN

JFBR

LXEH

MEDS

MESO

MNKD

MRAI

MRNA

MSTR

NBTX

NWTN

PLSE

PSTX

RVSN

SELX

SMCI

STAA

TCBP

VNET

Shares of  Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients.

Mesoblast shares jumped 13.4% to $2.4399 on Monday.

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Genie Energy Ltd. Class B Common Stock Stock

Genie Energy Ltd

GANFENG LITHIUM GROUP CO by Ganfeng Lithium Group Co. Ltd.

Ganfeng Lithium Group Co Ltd

GANFENG LITHIUM UNSP/ADR by Ganfeng Lithium Group Co. Ltd.

Genie Energy, Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNE#NYSE">GNE</a>), a leading retail energy and renewable energy solutions provider, today provided an update on its consumer insurance initiative.
Earlier his year, the company announced an initiative to expand its consumer products portfolio with insurance offerings, and formed a wholly-owned, "captive" self-insurance subsidiary to enhance the Company's risk management strategy.
"To date, we have secured insurance broker licenses in seven key states and begun to offer third-party insurance solutions through our existing sales channels to our customer base," said Genie's CEO, Michael Stein. "We expect the economics of our offerings to strengthen gradually as we build out and bring to market internally-generated consumer offerings in the coming months."
Genie also announced that has expanded the coverage provided to the company through its captive insurance subsidiary. In the fourth quarter of 2024, Genie expects to pay its subsidiary approximately $40 million in premiums for expanded insurance coverage to address various additional risks.
As required by GAAP, Genie expects to record a non-recurring, non-cash charge of approximately $31 million in the fourth quarter as an insurance loss reserve related to the expanded coverage. This loss reserve will be reflected in Genie's fourth quarter and full year 2024 financial results under GAAP. However, the Company does not expect this charge to impact its reported measure of Adjusted EBITDA.
The $40 million in premium payments made to the Captive will remain on Genie's consolidated balance sheet within its reported measures of short and long-term restricted cash, and other short and long-term assets. The funds will be available for investment by the Captive as determined by Genie management to support Genie Energy's strategic objectives consistent with regulations and the Captive's position.
Genie reported Genie reported cash and cash equivalents, short and long-term restricted cash, and marketable equity securities of $191.7 million as of September 30, 2024.

Genie Energy Advances Insurance Strategy; Expects To Pay Its Subsidiary ~$40M In Premiums For Expanded Insurance Coverage To Address Various Additional Risks

It was reported on November 22, that AVI GOLDIN, CFO at Genie Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNE#NYSE">GNE</a>) executed a significant insider sell, according to an SEC filing.
What Happened: After conducting a thorough analysis, GOLDIN sold 7,300 shares of Genie Energy. This information was disclosed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001528356/000095017024129977//Archives/edgar/data/1528356/000095017024129977/0000950170-24-129977-index.htm">U.S. Securities and Exchange Commission</a> on Friday. The total transaction value is $112,551.
Tracking the Friday's morning session, Genie Energy shares are trading at $15.9, showing a down of 0.0%.
<h3>Discovering Genie Energy: A Closer Look</h3>
Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.
<h3>Genie Energy: Financial Performance Dissected</h3>
Revenue Challenges: Genie Energy's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -10.5%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Utilities sector.
Analyzing Profitability Metrics:
<ul>
<li>
Gross Margin: The company faces challenges with a low gross margin of 33.87%, suggesting potential difficulties in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Genie Energy's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.38.
</li>
</ul>
Debt Management: Genie Energy's debt-to-equity ratio is below the industry average. With a ratio of 0.01, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Navigating Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: Genie Energy's stock is currently priced at a premium level, as reflected in the higher-than-average P/E ratio of 198.75.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 1.0, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): At 43.27, the company's EV/EBITDA ratio outperforms industry norms, reflecting positive market perception. This positioning indicates optimistic expectations for the company's future performance.
</li>
</ul>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Exploring the Significance of Insider Trading</h3>
Investors should view insider transactions as part of a multifaceted analysis and not rely solely on them for decision-making.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Essential Transaction Codes Unveiled</h3>
For <a href="https://www.benzinga.com/money/investing-tools">investors</a>, a primary focus lies on transactions occurring in the open market, as indicated in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001528356">Check Out The Full List Of Genie Energy's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Massive Insider Trade At Genie Energy

Genie Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNE#NYSE">GNE</a>) reported quarterly earnings of $0.41 per share. This is a 22.64 percent decrease over earnings of $0.53 per share from the same period last year. The company reported $111.92 million in sales this quarter. This is a 10.47 percent decrease over sales of $125.00 million the same period last year.

Genie Energy Q3 EPS $0.41 Down From $0.53 YoY, Sales $111.92M Down From $125.00M YoY

MICHAEL STEIN, Chief Executive Officer at Genie Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNE#NYSE">GNE</a>), reported an insider buy on August 6, according to a new SEC filing. 
What Happened: A Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001528356/000095017024091121//Archives/edgar/data/1528356/000095017024091121/0000950170-24-091121-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday unveiled that STEIN made a notable purchase of 125,000 shares of Genie Energy, valuing at $2,125,000.
The latest update on Tuesday morning shows Genie Energy shares down by 2.53%, trading at $15.04.
<h3>Discovering Genie Energy: A Closer Look</h3>
Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.
<h3>Key Indicators: Genie Energy's Financial Health</h3>
Revenue Growth: Genie Energy displayed positive results in 3 months. As of 31 March, 2024, the company achieved a solid revenue growth rate of approximately 13.69%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Utilities sector.
Analyzing Profitability Metrics:
<ul>
<li>
Gross Margin: The company faces challenges with a low gross margin of 28.23%, suggesting potential difficulties in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): With an EPS below industry norms, Genie Energy exhibits below-average bottom-line performance with a current EPS of 0.3.
</li>
</ul>
Debt Management: Genie Energy's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.0.
Financial Valuation Breakdown:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a higher-than-average P/E ratio of 40.61, Genie Energy's stock is perceived as being overvalued in the market.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 0.91, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Boasting an EV/EBITDA ratio of 21.17, Genie Energy demonstrates a robust market valuation, outperforming industry benchmarks.
</li>
</ul>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Pay Attention to Insider Transactions</h3>
Investors should view insider transactions as part of a multifaceted analysis and not rely solely on them for decision-making.
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Unlocking the Meaning of Transaction Codes</h3>
In the domain of transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their focus to those taking place in the open market, as meticulously outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001528356">Check Out The Full List Of Genie Energy's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Eye On Growth: MICHAEL STEIN Adds $2.12M Of Genie Energy Stock To Portfolio

A significant insider buy by AVI GOLDIN, CFO at Genie Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNE#NYSE">GNE</a>), was executed on August 6, and reported in the recent SEC filing.
What Happened: In a Form 4 filing on Tuesday with the <a href="https://www.sec.gov/Archives/edgar/data/0001528356/000095017024091122//Archives/edgar/data/1528356/000095017024091122/0000950170-24-091122-index.htm">U.S. Securities and Exchange Commission</a>, it was disclosed that GOLDIN bought 32,100 shares of Genie Energy, amounting to a total of $545,700.
During Tuesday's morning session, Genie Energy shares down by 2.53%, currently priced at $15.04.
<h3>Get to Know Genie Energy Better</h3>
Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.
<h3>A Deep Dive into Genie Energy's Financials</h3>
Revenue Growth: Genie Energy displayed positive results in 3 months. As of 31 March, 2024, the company achieved a solid revenue growth rate of approximately 13.69%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Utilities sector.
Profitability Metrics: Unlocking Value
<ul>
<li>
Gross Margin: The company shows a low gross margin of 28.23%, indicating concerns regarding cost management and overall profitability relative to its industry counterparts.
</li>
<li>
Earnings per Share (EPS): Genie Energy's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.3.
</li>
</ul>
Debt Management: Genie Energy's debt-to-equity ratio is below the industry average. With a ratio of 0.0, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: Genie Energy's current Price to Earnings (P/E) ratio of 40.61 is higher than the industry average, indicating that the stock may be overvalued according to market sentiment.
</li>
<li>
Price to Sales (P/S) Ratio: With a P/S ratio of 0.91 below industry standards, the stock shows potential undervaluation, making it an appealing investment option for those focusing on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): A high EV/EBITDA ratio of 21.17 reflects market recognition of Genie Energy's value, positioning it as more highly valued compared to industry peers.
</li>
</ul>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Exploring the Significance of Insider Trading</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
From a legal standpoint, the term "insider" pertains to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as outlined in Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and significant hedge funds. These insiders are mandated to inform the public of their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
A company insider's new purchase is a indicator of their positive anticipation for a rise in the stock.
While insider sells may not necessarily reflect a bearish view and can be motivated by various factors.
<h3>Deciphering Transaction Codes in Insider Filings</h3>
Surveying the realm of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often give prominence to those unfolding in the open market, systematically detailed in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001528356">Check Out The Full List Of Genie Energy's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Bullish Move: AVI GOLDIN Shows Confidence, Acquires $545K In Genie Energy Stock

Guidance

Genie Energy Says On Track To Achieve Full Year Guidance Of $40M - $50M In Consolidated Adjusted EBITDA

Genie Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNE#NYSE">GNE</a>) reported quarterly earnings of $0.37 per share. This is a 17.78 percent decrease over earnings of $0.45 per share from the same period last year. The company reported $90.70 million in sales this quarter. This is a 2.96 percent decrease over sales of $93.46 million the same period last year.

Genie Energy Q2 Adj $0.37 Down From $0.45 YoY, Sales $90.70M Down From $93.46M YoY

Genie Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNE#NYSE">GNE</a>) reported quarterly earnings of $0.33 per share. This is a 38.89 percent decrease over earnings of $0.54 per share from the same period last year. The company reported $119.69 million in sales this quarter. This is a 13.69 percent increase over sales of $105.28 million the same period last year.

Genie Energy Q1 EPS $0.33 Down From $0.54 YoY, Sales $119.69M Up From $105.28M YoY

The CNN Money Fear and Greed index remained in the &quot;Greed&quot; zone on Monday.
U.S. stocks closed mixed on Monday, with the S&amp;P 500 settling lower for the second straight session. All three major indices closed recorded losses last week, with the S&amp;P 500 falling 0.26% and the blue-chip Dow declining 0.93%.
Data on the consumer price index for February will be released on Tuesday. Analysts expect the CPI to increase 3.1% on an annualized basis.
EQT Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eqt#NYSE">EQT</a>) announced that it entered into a definitive merger agreement to acquire Equitrans Midstream Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/etrn#NYSE">ETRN</a>). Shares of Genie Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gne#NYSE">GNE</a>) fell more than 9% on Monday following fourth-quarter results.
Most sectors on the S&amp;P 500 closed on a negative note, with industrials, consumer discretionary, and real estate stocks recording the biggest losses on Monday. However, materials and energy stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed higher by around 47 points to 38,769.66 on Monday. The S&amp;P 500 fell 0.11% at 5,117.94, while the Nasdaq Composite fell 0.41% at 16,019.27 during Monday&rsquo;s session.
Investors are awaiting earnings results from International Game Technology PLC (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/igt#NYSE">IGT</a>), IHS Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ihs#NYSE">IHS</a>), and Kohl&#39;s Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kss#NYSE">KSS</a>) today.
At a current reading of 66.6, the index remained in the &quot;Greed&quot; zone on Monday, versus a prior reading of 66.6.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
&nbsp;
Read Next: <a href="https://www.benzinga.com/news/24/03/37584146/top-5-risk-off-stocks-that-may-plunge-this-quarter"> Top 5 Risk Off Stocks That May Plunge This Quarter </a>

Fear & Greed Index Remains In 'Greed' Zone Ahead Of Inflation Data; S&P 500 Falls For 2nd Session

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning higher on Monday.
The Dow traded up 0.08% to 38,753.49&nbsp;while the NASDAQ fell 0.20% to 16,052.34. The S&amp;P 500 also fell, dropping, 0.14% to 5,116.66.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37578817/cramer-says-this-healthcare-stock-can-go-higher-calls-manhattan-associates-a-winner"> Cramer Says This Healthcare Stock Can Go Higher, Calls Manhattan Associates &#39;A Winner&#39;</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Materials shares jumped by 0.9% on Monday.
In trading on Monday, industrials shares fell by 0.8%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
EQT Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eqt#NYSE">EQT</a>) announced that it entered into a definitive merger agreement to acquire Equitrans Midstream Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/etrn#NYSE">ETRN</a>).
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
GDS Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gds#NASDAQ">GDS</a>) shares shot up 22% to $7.80 following a report suggesting Hillhouse and Boyu are in talks to invest in the company&#39;s Southeast Asia data center business.
Shares of Fangdd Network Group Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/duo#NASDAQ">DUO</a>) got a boost, surging 20% to $0.7234 after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services <a href="https://www.benzinga.com/money/best-sectors-to-invest-in-right-now/">sector</a>
Lexicon Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxrx#NASDAQ">LXRX</a>) shares were also up, gaining 22% to $2.6550 after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Eltek Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eltk#NASDAQ">ELTK</a>) shares dropped 22% to $10.80 after the company announced downbeat quarterly earnings.
Shares of Genie Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gne#NYSE">GNE</a>) were down 10% to $16.98 following fourth-quarter results.
Ventyx Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtyx#NASDAQ">VTYX</a>) was down, falling 20% to $7.89. Ventyx Biosciences reported clinical data for its NLRP3 inhibitor portfolio and issued pipeline updates at Virtual Investor Event.
Also Check This Out:<a href="https://www.benzinga.com/news/24/03/37584146/top-5-risk-off-stocks-that-may-plunge-this-quarter"> Top 5 Risk Off Stocks That May Plunge This Quarter</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 0.2% to $77.84 while gold traded up 0.1% at $2,186.40.
Silver traded up 0.6% to $24.69 on Monday while copper rose 0.9% to $3.9275.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were mostly lower today. The eurozone&rsquo;s STOXX 600 fell 0.35%, London&rsquo;s FTSE 100 rose 0.12% while Spain&rsquo;s IBEX 35 Index rose 0.19% The German DAX fell 0.38% French CAC 40 fell 0.10% while Italy&rsquo;s FTSE MIB Index fell 0.27%.
Spanish retail trade rose by 0.3% year-over-year in January versus a revised 2.7% gain in the previous month.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mixed on Monday, with Japan&rsquo;s Nikkei 225 dipping 2.19%, Hong Kong&rsquo;s Hang Seng Index gaining 1.43%, China&rsquo;s Shanghai Composite Index gaining 0.74% and India&rsquo;s S&amp;P BSE Sensex falling 0.81%.
Chinese vehicle sales dipped by 19.9% year-over-year to 1.58 million units in February versus a 47.9% surge in the prior month. Japanese machine tool orders declined by 8% year-over-year to JPY 114,154 million in February. Japan&#39;s GDP expanded by 0.1% quarter-over-quarter in the fourth quarter versus a 0.8% contraction in the third quarter.
&nbsp;
<h3>Economics</h3>
&nbsp;
No economic report of significance is due for Monday
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/03/37578904/how-to-earn-500-a-month-from-calavo-growers-ahead-of-q1-earnings"> How To Earn $500 A Month From Calavo Growers Ahead Of Q1 Earnings</a>

Shares of Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) rose sharply during Monday&rsquo;s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients.
Mesoblast shares jumped 13.4% to $2.4399 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Kidpik Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pik#NASDAQ">PIK</a>) gained 238% to $9.15. Kidpik recently announced a 1-for 5 reverse stock split.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcbp#NASDAQ">TCBP</a>) shares surged 149% to $2.6450.</li>
<li>TRxADE HEALTH, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meds#NASDAQ">MEDS</a>) gained 114.6% to $17.26. TRxADE Health recently announced a special cash dividend of $8 per share.</li>
<li>Fangdd Network Group Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/duo#NASDAQ">DUO</a>) shares climbed 108% to $1.2593 after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services <a href="https://www.benzinga.com/money/best-sectors-to-invest-in-right-now/">sector</a>.</li>
<li>GDS Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gds#NASDAQ">GDS</a>) shares gained 23.7% to $7.93 following a report suggesting Hillhouse and Boyu are in talks to invest in the company&#39;s Southeast Asia data center business.</li>
<li>Solidion Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sti#NASDAQ">STI</a>) rose 23.3% to $0.9620.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kc#NASDAQ">KC</a>) shares gained 23.1% to $3.31. Kingsoft Cloud is expected to report fourth-quarter financial results on March 20, 2024.</li>
<li>EHang Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eh#NASDAQ">EH</a>) gained 21.7% to $13.89. EHang Holdings is expected to release its unaudited financial results for the fourth quarter on March 15, 2024.</li>
<li>Bally&#39;s Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/baly#NYSE">BALY</a>) gained 21.5% to $12.90. Standard General delivered a non-binding letter to the board of directors of Bally&#39;s proposing a transaction under which it would acquire all of the outstanding shares of common stock for $15/share, not currently owned by the company.</li>
<li>Rail Vision Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvsn#NASDAQ">RVSN</a>) climbed 21.2% to $3.43. Rail Vision received an order from a Class 1 US railroad company for its AI-based safety system.</li>
<li>Marpai, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrai#NASDAQ">MRAI</a>) gained 18.7% to $2.0899.</li>
<li>bioAffinity Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/biaf#NASDAQ">BIAF</a>) climbed 18.3% to $1.81.</li>
<li>Lixiang Education Holding Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxeh#NASDAQ">LXEH</a>) gained 15.6% to $4.8797.</li>
<li>Lexicon Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxrx#NASDAQ">LXRX</a>) jumped 13.4% to $2.4650 after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.</li>
<li>NWTN Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nwtn#NASDAQ">NWTN</a>) gained 13.4% to $4.8082.</li>
<li>Pulse Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plse#NASDAQ">PLSE</a>) rose 12.7% to $10.86. Pulse Biosciences announced FDA 510(k) clearance for Cellfx NSPFA Percutaneous Electrode System.</li>
<li>Bilibili Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bili#NASDAQ">BILI</a>) gained 12.7% to $12.55 after JP Morgan upgraded the stock from Underweight to Neutral and raised its price target from $10 to $11. The stock is also gaining amid overall China strength following the annual National People&#39;s Congress event.</li>
<li>Graphite Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grph#NASDAQ">GRPH</a>) climbed 11.7% to $3.5080. Graphite Bio declared a special dividend in connection with proposed merger with Lenz Therapeutics.</li>
<li>STAAR Surgical Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/staa#NASDAQ">STAA</a>) jumped 10% to $39.45 after Stifel upgraded the stock from Hold to Buy and raised its price target from $30 to $50.</li>
<li>VNET Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vnet#NASDAQ">VNET</a>) rose 9.8% to $1.68.</li>
<li>Moderna, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrna#NASDAQ">MRNA</a>) gained 9.2% to $112.51.</li>
<li>Ituran Location and Control Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/itrn#NASDAQ">ITRN</a>) climbed 7.8% to $28.42.</li>
<li>NuScale Power Corporation(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smr#NYSE">SMR</a>) gained 7% to $5.87. NuScale Power is expected to release fourth quarter results on March 14, 2024.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) gained 4.7% to $1,492.07 amid continued strength in Bitcoin.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Jeffs&#39; Brands Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jfbr#NASDAQ">JFBR</a>) fell 45.2% to $0.8650.</li>
<li>Eltek Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eltk#NASDAQ">ELTK</a>) shares fell 20.9% to $11.00 after the company announced downbeat quarterly earnings.</li>
<li>CERo Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cero#NASDAQ">CERO</a>) declined 22% to $3.0822 after jumping 28% on Friday. CERo Therapeutics recently announced the publication of preclinical research analyzing CER-1236 in targeting Acute Myelogenous Leukemia tumor cells from human patients.</li>
<li>The Real Good Food Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgf#NASDAQ">RGF</a>) fell 19.7% to $0.5536.</li>
<li>Ventyx Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtyx#NASDAQ">VTYX</a>) dipped 18.5% to $8.09. Ventyx Biosciences reported clinical data for its NLRP3 inhibitor portfolio and issued pipeline updates at Virtual Investor Event.</li>
<li>Lytus Technologies Holdings PTV. Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyt#NASDAQ">LYT</a>) fell 15.3% to $6.78 after declining 8% on Friday. Lytus Technologies, last week, announced the launch of Lytus Cloud.</li>
<li>Next.e.GO N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egox#NASDAQ">EGOX</a>) declined 15.3% to $0.0727.</li>
<li>MoneyLion Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ml#NYSE">ML</a>) fell 15% to $63.36.</li>
<li>Semilux International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/selx#NASDAQ">SELX</a>) fell 14.8% to $1.4403 after jumping 69% on Friday.</li>
<li>Lytus Technologies Holdings PTV. Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyt#NASDAQ">LYT</a>) fell 14.6% to $6.83.</li>
<li>Barnes &amp; Noble Education, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bned#NYSE">BNED</a>) dipped 13.8% to $0.7832. Barnes &amp; Noble Education recently rescheduled its third quarter fiscal year 2024 earnings release.</li>
<li>Psyence Biomedical Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbm#NASDAQ">PBM</a>) fell 13.4% to $1.8272 after jumping 66% on Friday. The company recently announced its subsidiary, Psyence Australia, received Human Research Ethics Committee approval to initiate its Phase IIb study.</li>
<li>Immuron Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imrn#NASDAQ">IMRN</a>) shares tumbled 12.5% to $3.3252 after dipping 16% on Friday.</li>
<li>Genie Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gne#NYSE">GNE</a>) fell 12% to $16.67 following fourth-quarter results.</li>
<li>Nanobiotix S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbtx#NASDAQ">NBTX</a>) dipped 9.8% to $6.35.</li>
<li>Avenue Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atxi#NASDAQ">ATXI</a>) fell 8.9% to $0.1749 after surging 10% on Friday.</li>
<li>Super Micro Computer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) dipped 8.8% to $1,039.60.</li>
<li>MannKind Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnkd#NASDAQ">MNKD</a>) declined 8.7% to $4.81. MannKind announced initial meal challenge data from INHALE-3 Phase 4 U.S. trial comparing afrezza head-to-head with multiple daily injections and insulin pumps.</li>
<li>Poseida Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pstx#NASDAQ">PSTX</a>) fell 8.1% to $3.74.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37584162/wall-streets-most-accurate-analysts-say-buy-these-3-energy-stocks-with-over-3-dividend-y"> Wall Street&#39;s Most Accurate Analysts Say Buy These 3 Energy Stocks With Over 3% Dividend Yields</a>

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session

WIIM

Genie Energy shares are trading lower after the company reported a year-over-year decrease Q4 adjusted EPS results.

U.S. stocks traded lower midway through trading, with the Dow Jones index dipping over 50 points on Monday.
The Dow traded down 0.16% to 38,662.09 while the NASDAQ fell 0.26% to 16,043.75. The S&amp;P 500 also fell, dropping, 0.27% to 5,110.11.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37578817/cramer-says-this-healthcare-stock-can-go-higher-calls-manhattan-associates-a-winner"> Cramer Says This Healthcare Stock Can Go Higher, Calls Manhattan Associates &#39;A Winner&#39;</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Materials shares jumped by 0.3% on Monday.
In trading on Monday, industrials shares fell by 1.1%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
EQT Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eqt#NYSE">EQT</a>) announced that it entered into a definitive merger agreement to acquire Equitrans Midstream Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/etrn#NYSE">ETRN</a>).
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
GDS Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gds#NASDAQ">GDS</a>) shares shot up 21% to $7.77 following a report suggesting Hillhouse and Boyu are in talks to invest in the company&#39;s Southeast Asia data center business.
Shares of Fangdd Network Group Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/duo#NASDAQ">DUO</a>) got a boost, surging 48% to $0.8952 after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services <a href="https://www.benzinga.com/money/best-sectors-to-invest-in-right-now/">sector</a>
Lexicon Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxrx#NASDAQ">LXRX</a>) shares were also up, gaining 19% to $2.5790 after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Eltek Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eltk#NASDAQ">ELTK</a>) shares dropped 21% to $11.05 after the company announced downbeat quarterly earnings.
Shares of Genie Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gne#NYSE">GNE</a>) were down 11% to $16.93 following fourth-quarter results.
Ventyx Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtyx#NASDAQ">VTYX</a>) was down, falling 19% to $8.07. Ventyx Biosciences reported clinical data for its NLRP3 inhibitor portfolio and issued pipeline updates at Virtual Investor Event.
Also Check This Out:<a href="https://www.benzinga.com/news/24/03/37584146/top-5-risk-off-stocks-that-may-plunge-this-quarter"> Top 5 Risk Off Stocks That May Plunge This Quarter</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded up 0.2% to $78.17 while gold traded up 0.2% at $2,189.80.
Silver traded up 0.3% to $24.615 on Monday while copper rose 0.4% to $3.9085.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were mostly lower today. The eurozone&rsquo;s STOXX 600 fell 0.57%, London&rsquo;s FTSE 100 fell 0.30% while Spain&rsquo;s IBEX 35 Index rose 0.10% The German DAX fell 0.63% French CAC 40 fell 0.38% while Italy&rsquo;s FTSE MIB Index fell 0.53%.
Spanish retail trade rose by 0.3% year-over-year in January versus a revised 2.7% gain in the previous month.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mixed on Monday, with Japan&rsquo;s Nikkei 225 dipping 2.19%, Hong Kong&rsquo;s Hang Seng Index gaining 1.43%, China&rsquo;s Shanghai Composite Index gaining 0.74% and India&rsquo;s S&amp;P BSE Sensex falling 0.81%.
Chinese vehicle sales dipped by 19.9% year-over-year to 1.58 million units in February versus a 47.9% surge in the prior month. Japanese machine tool orders declined by 8% year-over-year to JPY 114,154 million in February. Japan&#39;s GDP expanded by 0.1% quarter-over-quarter in the fourth quarter versus a 0.8% contraction in the third quarter.
&nbsp;
<h3>Economics</h3>
&nbsp;
No economic report of significance is due for Monday.
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/03/37578904/how-to-earn-500-a-month-from-calavo-growers-ahead-of-q1-earnings"> How To Earn $500 A Month From Calavo Growers Ahead Of Q1 Earnings</a>

Crude Oil Edges Higher; Lexicon Pharmaceuticals Shares Jump

U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.
Shares of EQT Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eqt#NYSE">EQT</a>) fell sharply during Monday&rsquo;s session after the company announced that it entered into a definitive merger agreement to <a href="https://www.benzinga.com/markets/equities/24/03/37583705/why-eqt-equitrans-midstream-shares-are-moving-premarket-monday">acquire Equitrans Midstream</a>.
EQT shares fell 8.4% to $34.37 on Monday.
Here are some other big stocks recording losses in today&rsquo;s session.
<ul>
<li>Ventyx Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtyx#NASDAQ">VTYX</a>) shares tumbled 18.5% to $8.09. Ventyx Biosciences reported clinical data for its NLRP3 inhibitor portfolio and issued pipeline updates at Virtual Investor Event.</li>
<li>MoneyLion Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ml#NYSE">ML</a>) dipped 15% to $63.36.</li>
<li>Genie Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gne#NYSE">GNE</a>) declined 12% to $16.67 following fourth-quarter results.</li>
<li>Nanobiotix S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbtx#NASDAQ">NBTX</a>) dipped 9.8% to $6.35.</li>
<li>Pagaya Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgy#NASDAQ">PGY</a>) fell 9.6% to $16.54.</li>
<li>Bitfarms Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bitf#NASDAQ">BITF</a>) fell 9% to $2.4290. Bitfarms purchased additional miners to reach 21 EH/s in 2024.</li>
<li>Quantum-Si incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qsi#NASDAQ">QSI</a>) declined 9% to $2.03.</li>
<li>Super Micro Computer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) dipped 8.8% to $1,039.60.</li>
<li>MannKind Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnkd#NASDAQ">MNKD</a>) dipped 8.7% to $4.81. MannKind announced initial meal challenge data from INHALE-3 Phase 4 U.S. trial comparing afrezza head-to-head with multiple daily injections and insulin pumps.</li>
<li>Applied Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aplt#NASDAQ">APLT</a>) fell 8.4% to $6.35.</li>
<li>Poseida Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pstx#NASDAQ">PSTX</a>) declined 8.1% to $3.74.</li>
<li>Arrowhead Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arwr#NASDAQ">ARWR</a>) fell 7.6% to $30.90. Arrowhead Pharmaceuticals recently announced that it initiated its Phase 1/2a study of ARO-DM1 for the treatment of type 1 myotonic dystrophy.</li>
<li>Arcutis Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arqt#NASDAQ">ARQT</a>) dipped 7.6% to $10.31. Arcutis promoted Todd Tucker to Chief Human Resources Officer.</li>
<li>Carvana Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cvna#NYSE">CVNA</a>) fell 6.3% to $79.96.</li>
<li>Celestica Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cls#NYSE">CLS</a>) fell 5.7% to $43.45. Cormark Securities analyst Jesse Pytlak initiated coverage on Celestica with a Buy rating and announced a price target of $56.</li>
<li>NOVONIX Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nvx#NYSE">NVX</a>) fell 5.2% to $2.37.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/03/37584146/top-5-risk-off-stocks-that-may-plunge-this-quarter"> Top 5 Risk Off Stocks That May Plunge This Quarter</a>

APLT

ARQT

ARWR

BITF

CVNA

Nuveen California Dividend Advantage Municipal Fund 2

EQT, Genie Energy And Other Big Stocks Moving Lower On Monday

Genie Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNE#NYSE">GNE</a>) reported quarterly adjusted&nbsp;earnings of $0.37 per share. This is a 39.34 percent decrease over earnings of $0.61 per share from the same period last year. The company reported $104.90 million in sales this quarter. This is a 28.87 percent increase over sales of $81.40 million the same period last year.

Genie Energy Q4 Adj  EPS $0.37 Down From $0.61 YoY, Sales $104.90M Up From $81.40M YoY

<h3>Companies Reporting Before The Bell</h3>
&bull; Ballard Power Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDP#NASDAQ">BLDP</a>) is estimated to report quarterly loss at $0.13 per share on revenue of $34.20 million.
&bull; Endeavor Gr Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDR#NYSE">EDR</a>) is likely to report quarterly earnings at $0.02 per share on revenue of $49.47 million.
&bull; SilverCrest Metals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SILV#AMEX">SILV</a>) is likely to report quarterly earnings at $0.10 per share on revenue of $44.09 million.
&bull; Global X Silver Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIL#NYSE">SIL</a>) is likely to report quarterly earnings at $0.10 per share on revenue of $44.09 million.
&bull; Legend Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEGN#NASDAQ">LEGN</a>) is projected to report quarterly loss at $0.83 per share on revenue of $86.52 million.
&bull; Genie Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNE#NYSE">GNE</a>) is projected to report earnings for its fourth quarter.
&bull; Overseas Shipholding Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSG#NYSE">OSG</a>) is expected to report earnings for its fourth quarter.
&bull; Eltek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTK#NASDAQ">ELTK</a>) is projected to report quarterly earnings at $0.31 per share on revenue of $12.20 million.
&bull; Endeavour Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXK#NYSE">EXK</a>) is estimated to report quarterly earnings at $0.02 per share on revenue of $49.47 million.
&bull; Fortrea Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) is projected to report quarterly earnings at $0.24 per share on revenue of $775.89 million.
<h3>Companies Reporting After The Bell</h3>
&bull; Hesai Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>) is likely to report quarterly loss at $0.11 per share on revenue of $81.11 million.
&bull; PLAYSTUDIOS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYPS#NASDAQ">MYPS</a>) is expected to report quarterly loss at $0.02 per share on revenue of $75.31 million.
&bull; Ocular Therapeutix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCUL#NASDAQ">OCUL</a>) is estimated to report quarterly loss at $0.30 per share on revenue of $15.71 million.
&bull; Asana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) is estimated to report quarterly loss at $0.10 per share on revenue of $167.68 million.
&bull; Calavo Growers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVGW#NASDAQ">CVGW</a>) is projected to report quarterly earnings at $0.17 per share on revenue of $252.67 million.
&bull; Mission Produce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVO#NASDAQ">AVO</a>) is likely to report quarterly loss at $0.06 per share on revenue of $210.75 million.
&bull; Casey&#39;s General Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CASY#NASDAQ">CASY</a>) is estimated to report quarterly earnings at $2.13 per share on revenue of $3.54 billion.
&bull; Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) is estimated to report quarterly earnings at $1.38 per share on revenue of $13.31 billion.
&bull; Cango (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CANG#NYSE">CANG</a>) is estimated to report earnings for its fourth quarter.
&bull; Beachbody Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BODI#NYSE">BODI</a>) is estimated to report quarterly loss at $3.12 per share on revenue of $108.75 million.
&bull; Ranpak Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PACK#NYSE">PACK</a>) is expected to report quarterly loss at $0.04 per share on revenue of $87.04 million.
&bull; Alto Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTO#NASDAQ">ALTO</a>) is expected to report quarterly loss at $0.08 per share on revenue of $292.76 million.
&bull; CytomX Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTMX#NASDAQ">CTMX</a>) is expected to report quarterly loss at $0.03 per share on revenue of $21.04 million.
&bull; Yalla Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YALA#NYSE">YALA</a>) is expected to report earnings for its fourth quarter.
&bull; Assertio Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASRT#NASDAQ">ASRT</a>) is projected to report quarterly loss at $0.02 per share on revenue of $33.81 million.
&bull; Smart Sand (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SND#NASDAQ">SND</a>) is expected to report quarterly loss at $0.06 per share on revenue of $57.70 million.
&bull; Bowman Consulting Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWMN#NASDAQ">BWMN</a>) is likely to report quarterly loss at $0.07 per share on revenue of $90.66 million.
&bull; LifeMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFMD#NASDAQ">LFMD</a>) is projected to report quarterly loss at $0.14 per share on revenue of $40.49 million.
&bull; Invesco KBW NASDAQ Fintech UCITS ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEK#NASDAQ">FTEK</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $6.90 million.
&bull; NN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNBR#NASDAQ">NNBR</a>) is expected to report quarterly loss at $0.08 per share on revenue of $113.15 million.
&bull; Alpha Teknova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKNO#NASDAQ">TKNO</a>) is expected to report quarterly loss at $0.24 per share on revenue of $8.32 million.
&bull; Monroe Cap (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRCC#NASDAQ">MRCC</a>) is estimated to report quarterly earnings at $0.27 per share on revenue of $16.56 million.
&bull; Vail Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) is estimated to report quarterly earnings at $5.98 per share on revenue of $1.15 billion.
&bull; NET Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPWR#NYSE">NPWR</a>) is projected to report quarterly loss at $0.05 per share on revenue of $1.50 million.
&bull; Heritage Insurance Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRTG#NYSE">HRTG</a>) is expected to report quarterly earnings at $0.46 per share on revenue of $185.11 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

ALTO

ASAN

ASRT

BLDP

The Beachbody Company, Inc. Class A Common Stock

BODI

BWMN

CANG

CASY

CTMX

CVGW

FTEK

FTRE

HRTG

HSAI

LEGN

LFMD

MRCC

MYPS

NNBR

NPWR

OCUL

ORCL

PACK

SILV

TKNO

YALA

Earnings Scheduled For March 11, 2024

<h3>What are Value Stocks?</h3>
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued. 
<h2>The following stocks are considered to be notable value stocks in the utilities sector:</h2>
<ol>
<li>TransAlta (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAC#NYSE">TAC</a>) - P/E: 3.97</li>
<li>Hawaiian Electric Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HE#NYSE">HE</a>) - P/E: 6.42</li>
<li>Genie Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNE#NYSE">GNE</a>) - P/E: 9.64</li>
<li>Entergy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETR#NYSE">ETR</a>) - P/E: 9.19</li>
<li>Cia Energetica DE Minas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIG#NYSE">CIG</a>) - P/E: 4.93</li>
</ol>
TransAlta's earnings per share for Q4 sits at $-0.2, whereas in Q3, they were at 1.05. Its most recent dividend yield is at 2.08%, which has decreased by 0.08% from 2.16% in the previous quarter.
Hawaiian Electric Indus saw a decrease in earnings per share from 0.56 in Q3 to $0.48 now. Its most recent dividend yield is at 3.75%, which has increased by 0.01% from 3.74% in the previous quarter.
Most recently, Genie Energy reported earnings per share at $0.53, whereas in Q2 earnings per share sat at $0.45. The company's most recent dividend yield sits at 1.61%, which has increased by 0.13% from 1.48% last quarter. 
Entergy has reported Q4 earnings per share at $0.52, which has decreased by 84.1% compared to Q3, which was 3.27. Its most recent dividend yield is at 4.56%, which has decreased by 0.29% from 4.85% in the previous quarter.
This quarter, Cia Energetica DE Minas experienced a decrease in earnings per share, which was $0.12 in Q2 and is now $0.03. 
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

5 Value Stocks To Watch In The Utilities Sector

<h3>What is a Value Stock?</h3>
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued. 
<h2>Benzinga Insights has compiled a list of value stocks in the utilities sector that may be worth watching:</h2>
<ol>
<li>Genie Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNE#NYSE">GNE</a>) - P/E: 9.49</li>
<li>Hawaiian Electric Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HE#NYSE">HE</a>) - P/E: 6.95</li>
<li>Entergy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETR#NYSE">ETR</a>) - P/E: 9.08</li>
<li>Enel Chile (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENIC#NYSE">ENIC</a>) - P/E: 2.86</li>
<li>TransAlta (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAC#NYSE">TAC</a>) - P/E: 4.15</li>
</ol>
Genie Energy's earnings per share for Q3 sits at $0.53, whereas in Q2, they were at 0.45. The company's most recent dividend yield sits at 1.61%, which has increased by 0.13% from 1.48% last quarter. 
Hawaiian Electric Indus's earnings per share for Q4 sits at $0.48, whereas in Q3, they were at 0.56. Most recently, the company reported a dividend yield of 3.75%, which has increased by 0.01% from last quarter's yield of 3.74%.
Entergy saw a decrease in earnings per share from 3.27 in Q3 to $0.52 now. Its most recent dividend yield is at 4.56%, which has decreased by 0.29% from 4.85% in the previous quarter.
Enel Chile saw an increase in earnings per share from 0.1 in Q2 to $0.14 now. Most recently, the company reported a dividend yield of 64.82%, which has decreased by 1.55% from last quarter's yield of 66.37%.
TransAlta has reported Q4 earnings per share at $-0.2, which has decreased by 119.05% compared to Q3, which was 1.05. Its most recent dividend yield is at 2.08%, which has decreased by 0.08% from 2.16% in the previous quarter.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

ENIC

5 Value Stocks In The Utilities Sector

<h3>Understanding Value Stocks</h3>
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock. 
<h2>The following stocks are considered to be notable value stocks in the utilities sector:</h2>
<ol>
<li>TransAlta (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAC#NYSE">TAC</a>) - P/E: 4.32</li>
<li>Genie Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNE#NYSE">GNE</a>) - P/E: 9.41</li>
<li>Cia Energetica DE Minas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIG#NYSE">CIG</a>) - P/E: 4.99</li>
<li>OPAL Fuels (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPAL#NASDAQ">OPAL</a>) - P/E: 6.46</li>
<li>Enel Chile (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENIC#NYSE">ENIC</a>) - P/E: 2.95</li>
</ol>
This quarter, TransAlta experienced an increase in earnings per share, which was $0.17 in Q2 and is now $1.05. Its most recent dividend yield is at 2.08%, which has decreased by 0.08% from 2.16% in the previous quarter.
Genie Energy has reported Q3 earnings per share at $0.53, which has increased by 17.78% compared to Q2, which was 0.45. The company's most recent dividend yield sits at 1.61%, which has increased by 0.13% from 1.48% last quarter. 
This quarter, Cia Energetica DE Minas experienced a decrease in earnings per share, which was $0.12 in Q2 and is now $0.03. Most recently, OPAL Fuels reported earnings per share at $-0.01, whereas in Q2 earnings per share sat at $-0.12. This quarter, Enel Chile experienced an increase in earnings per share, which was $0.1 in Q2 and is now $0.14. Most recently, the company reported a dividend yield of 64.82%, which has decreased by 1.55% from last quarter's yield of 66.37%.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

OPAL

A Look Into Utilities Sector Value Stocks

<h3>Understanding Value Stocks</h3>
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock. 
<h2>The following stocks are considered to be notable value stocks in the utilities sector:</h2>
<ol>
<li>OPAL Fuels (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPAL#NASDAQ">OPAL</a>) - P/E: 6.24</li>
<li>Cia Energetica DE Minas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIG#NYSE">CIG</a>) - P/E: 4.58</li>
<li>Enel Chile (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENIC#NYSE">ENIC</a>) - P/E: 2.63</li>
<li>Genie Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNE#NYSE">GNE</a>) - P/E: 9.65</li>
<li>TransAlta (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAC#NYSE">TAC</a>) - P/E: 4.31</li>
</ol>
This quarter, OPAL Fuels experienced an increase in earnings per share, which was $-0.12 in Q2 and is now $-0.01. This quarter, Cia Energetica DE Minas experienced a decrease in earnings per share, which was $0.12 in Q2 and is now $0.03. This quarter, Enel Chile experienced an increase in earnings per share, which was $0.1 in Q2 and is now $0.14. Its most recent dividend yield is at 64.82%, which has decreased by 1.55% from 66.37% in the previous quarter.
Genie Energy's earnings per share for Q3 sits at $0.53, whereas in Q2, they were at 0.45. Its most recent dividend yield is at 1.61%, which has increased by 0.13% from 1.48% in the previous quarter.
This quarter, TransAlta experienced an increase in earnings per share, which was $0.17 in Q2 and is now $1.05. Its most recent dividend yield is at 2.08%, which has decreased by 0.08% from 2.16% in the previous quarter.
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

The utilities industry is experiencing rapid growth, driven by the adoption of advanced technology and growing consumption. Amid this backdrop, it could be ideal to invest in sound utility stocks Brookfield Infrastructure (BIPC), Pampa Energía (PAM), and Genie Energy (GNE). Continue reading... During market volatility, investors seek stable investments and park their money in secure industries like utilities. The industry is currently flourishing rapidly with increasing economic activities and rising energy demand worldwide.
Given the industry's rosy outlook, it could be wise to invest in quality utility stocks Brookfield Infrastructure Corporation (<a href="https://stocknews.com/stock/BIPC/">BIPC</a>), Pampa Energía S.A. (<a href="https://stocknews.com/stock/PAM/">PAM</a>), and Genie Energy Ltd. (<a href="https://stocknews.com/stock/GNE/">GNE</a>) amid market turmoil.
The recent <a href="https://www.cbsnews.com/news/trump-election-impact-on-economy-taxes-inflation-your-money/">U.S. elections</a> have stirred significant market volatility, impacting every sector and consumers across the country.
Amidst the current market volatility, the utilities sector presents appealing investment opportunities for stability. The U.S. utilities market is poised to experience expansion in electricity sales and deal activities as economic activities and population grow along with evolution in the latest technologies.
The utilities market encompasses electricity, gas, and water companies, which are observing sharp demand with rising energy demand. Propelled by robust economic growth, intense heatwaves, and continued electrification across the globe, <a href="https://www.iea.org/reports/electricity-mid-year-update-july-2024/executive-summary">global electricity consumption is set to be at a higher pace</a> in 2024 and 2025 compared to previous years.
The 4% growth expected for 2024 beats the highest level of 2007. Also, for 2025 as well, 4% growth is anticipated. The increase in both years is influenced by strong electricity demand in multiple regions and countries, like China, India, and the United States.
Investors can turn to stable utilities stocks with continued demand through various business cycles and provide safety to your portfolio amidst the present market turmoil.
Considering the current economic outlook, let's examine the fundamentals of sound utility sector stock picks like BIPC, PAM, and GNE.
Brookfield Infrastructure Corporation (<a href="https://stocknews.com/stock/BIPC/">BIPC</a>)
BIPC owns and operates regulated natural gas transmission systems in Brazil. It is also engaged in regulated gas and electricity distribution operations in the United Kingdom, electricity transmission and distribution, and gas distribution in Australia.
BIPC's forward EV/Sales of 1.19x is 71.9% lower than the industry average of 4.23x. Similarly, its forward <a href="https://www.investopedia.com/terms/e/ev-ebitda.asp">EV/EBITDA</a> of 3.11x is 72.8% lower than the industry average of 11.44x. Also, its forward Price/Sales of 0.33x is 85.2% lower than the 2.22x industry average.
For the third quarter that ended September 30, 2024, BIPC's revenues increased 17.5% from the prior year's quarter to $5.27 billion, and its income before income tax was $313 million. The company's Funds from Operations came in at $599 million or $0.76 per unit, indicating growth of 7% and 4.1% year-over-year, respectively.
Over the past six months, BIPC's stock has surged 26.7% and 49.2% over the past year to close the last trading session at $43.54.
BIPC's robust outlook is reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, each weighted to an optimal degree.
The stock has a B grade for Growth, Quality, and Momentum. Within the <a href="https://stocknews.com/category/utilities-domestic/">Utilities - Domestic</a> industry, BIPC has topped the list of 59 stocks.
<a href="https://stocknews.com/stock/BIPC/">Click here</a> to access additional BIPC ratings for Value, Sentiment, and Stability.
Pampa Energía S.A. (<a href="https://stocknews.com/stock/PAM/">PAM</a>)
Headquartered in Buenos Aires, Argentina, PAM operates as an integrated power company. It operates in Electricity Generation; Oil and Gas; Petrochemicals; and Holding and Other Business segments. The company generates electricity through thermal plants, hydroelectric plants, and wind farms with a 5,332 megawatt (MW) installed capacity.
In terms of forward Price/Book, PAM is trading at 1.56x, 11.9% lower than the industry average of 1.77x. Also, the stock's forward non-GAAP P/E multiple of 7.83 is 56.3% lower than the industry average of 17.92. Further, its forward EV/EBITDA of 5.82x is 49.2% lower than the industry average of 11.44x.
For the third quarter that ended September 30, 2024, PAM's sales revenue increased 234.4% year-over-year to ARS 510.71 billion ($540 million). Its gross profit grew 174.2% from the year-ago value to ARS 166.41 billion ($175 million). Also, the company's net income for the period stood at ARS 139.40 billion ($146 million) and ARS 102.6 per share, up 174.8% and 175.8% year-over-year, respectively.
Analysts expect PAM's revenue for the fourth quarter (ending December 2024) to increase 151% year-over-year to $494.84 million. The company's EPS for the same period is expected to be $0.71.
PAM's stock gained 56.1% over the past six months and 100.5% over the past year to close the last trading session at $71.69.
PAM's POWR Ratings reflect its bright prospects. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system.
The stock is ranked #11 out of 53 stocks within the <a href="https://stocknews.com/category/utilities-foreign/">Utilities - Foreign</a> industry.
Check all the PAM ratings <a href="https://stocknews.com/stock/PAM/">here</a>.
Genie Energy Ltd. (<a href="https://stocknews.com/stock/GNE/">GNE</a>)
GNE engages in the supply of electricity and natural gas to residential and small business customers internationally. The company operates in two segments, GRE and Genie Renewables. It also develops, constructs, and operates solar energy projects for commercial and industrial customers.
On November 6, GNE announced to pay a quarterly dividend of $0.075 per share to Class A and Class B common stockholders on November 20, 2024, with a record date of November 12, 2024.
GNE pays an annual dividend of $0.30, which translates to a yield of 1.87% at the current share price. Its four-year average dividend yield is 2.13%. Moreover, the company's dividend payouts have increased at a CAGR of 52.3% over the past three years.
In the third quarter that ended on September 30, 2024, GNE reported total revenues of $111.92 million, and its gross profit was $37.91 million for the same period. Net income and EPS attributable to GNE common stockholders came in at $10.20 million and $0.38 for the quarter, respectively.
Furthermore, the company's adjusted EBITDA was $13.60 million for the period. GNE's cash and cash equivalents totaled $136.29 million as of September 30, 2024, compared to $107.61 million as of December 31, 2023.
Shares of GNE have surged 4.6% over the past six months to close the last trading session at $16.08.
GNE's bright prospects are reflected in its POWR Ratings. The stock has an overall grade of B, which equates to a Buy in our proprietary rating system.
GNE has a B grade for Quality, Sentiment, and Value. It has topped among the 57 stocks within the Utilities - Domestic industry.
Other ratings for GNE for Growth, Momentum, and Stability are also provided, <a href="https://stocknews.com/stock/GNE/">click here</a> to check.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
BIPC shares were trading at $43.00 per share on Wednesday afternoon, down $0.54 (-1.24%). Year-to-date, BIPC has gained 27.68%, versus a 27.04% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Rjkumari Saxena</h2> <img src='https:/wp-content/uploads/2024/04/Rajkumari-Saxena_Image-1.jpeg' style="float:left; padding:5px;width:125px;">Rajkumari started her career as a writer but gradually shifted her focus to financial journalism, leveraging her educational background in Commerce. Fascinated by the interplay of business and economic shifts in equities, she aspires to evolve as an analyst. With a knack for simplifying complex financial concepts, her mission is to empower investors with insights that lead to profitable decisions.<a href="https://stocknews.com/authors/?author=rajkumari-saxena">More...</a>The post <a href=https://stocknews.com/news/bipc-pam-gne-3-utility-stocks-providing-safe-harbor-amid-market-turmoil/>3 Utility Stocks Providing Safe Harbor Amid Market Turmoil</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Utility Stocks Providing Safe Harbor Amid Market Turmoil

Genie Energy Q3 Earnings: Soft Results With An Optimistic Outlook

Amid current economic uncertainties and market volatility, investing in defensive stocks appears as an ideal strategy for portfolio protection. Thus, quality defensive stocks Johnson & Johnson (JNJ), Pfizer (PFE), and Genie Energy (GNE) could be ideal portfolio additions as market volatility rises. Continue reading... Defensive stocks are stocks of companies that deliver products and services of essential or <a href="https://www.investopedia.com/terms/d/defensivestock.asp">necessary nature like healthcare, medicines</a>, basic utilities, consumer goods, etc. The demand for such companies is the same through various business cycles, and therefore, they offer stable income and growth prospects to investors, making them ideal investment choices during market uncertainties.
Given this backdrop, it could be wise to invest in quality defensive stocks Johnson &amp; Johnson (<a href="https://stocknews.com/stock/JNJ/">JNJ</a>), Pfizer Inc. (<a href="https://stocknews.com/stock/PFE/">PFE</a>), and Genie Energy Ltd. (<a href="https://stocknews.com/stock/GNE/">GNE</a>) for stability amid market volatility.
The U.S. economy has been showing mixed growth this year with each quarter. The economy grew at a 1.3% annualized rate in the first quarter, indicating slow expansion, whereas during the second quarter, the rate rose to 3.0%, fueled by strong household income growth and consumer spending.
Last week, the Bureau of Economic Analysis (BEA) <a href="https://www.commerce.gov/news/blog/2024/11/commerce-data-show-strong-economic-gains-due-americans-making-and-spending-more#:~:text=The%20U.S.%20Commerce%20Department's%20Bureau,Americans%20making%20and%20spending%20more.">reported GDP growth of 2.8%</a> at an annual rate in the third quarter of 2024, lower than the economists' estimate of 3.0%. The development during the quarter was driven by increasing consumer spending, which increased by 3.7%, the highest since the first quarter of 2023.
This market volatility has caused investors to seek defensive stocks that remain stable during market downturns and offer stable income through dividends and long-term growth opportunities.
Demand for healthcare amenities remains constant, as the need for medical treatments remains the same regardless of economic conditions. Hence, the sector offers investors stability and protection during market downturns. Likewise, basic utilities such as goods and services like water, gas, and electricity cannot be avoided or subset, given their necessity for survival.
Therefore, investing in defensive stocks amidst economic uncertainties is ideal due to constant consumer demand, stable income, and portfolio protection. Given these factors, let's delve deeper into the fundamentals of the top defensive stocks: JNJ, PFE, and GNE.
Johnson &amp; Johnson (<a href="https://stocknews.com/stock/JNJ/">JNJ</a>)
JNJ researches, develops, manufactures, and sells various products in the healthcare field internationally. The company operates in the Innovative Medicine and MedTech segments. It offers products for various therapeutic areas, like immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis.
On October 28, JNJ announced results from the Phase 3 GRAVITI study of TREMFYA&#xAE; (guselkumab), the first and only IL-23 inhibitor. TREMFYA showed robust subcutaneous induction and maintenance therapy results, demonstrating significant clinical remission and endoscopic response at 48 weeks in adults with moderately to severely active CD.
Upon FDA approval, TREMFYA&#xAE; could become the first IL-23 treatment to offer a subcutaneous and intravenous (IV) induction regimen for patients with Crohn's disease (CD).
On October 9, JNJ completed the acquisition of V-Wave Ltd., a privately held company focused on developing innovative treatment options for patients with heart failure. The acquisitions added V-Wave's novel and minimally invasive Ventura&#xAE; interatrial shunt to the Johnson &amp; Johnson MedTech portfolio and will also strengthen its position in the cardiovascular disease segment.
During the nine months that ended September 30, 2024, JNJ's reported sales increased 4% year-over-year to $66.30 billion. Its <a href="https://www.investopedia.com/terms/g/grossprofit.asp#:~:text=Gross%20profit%2C%20or%20gross%20income,fluctuate%20compared%20to%20production%20output.">gross profit</a> rose 4.4% year-over-year to $45.96 billion. The company's net earnings from continuing operations of $10.64 billion and $4.83 indicate increases of 15.7% and 24.1% from the prior year's period, respectively.
Analysts expect JNJ's EPS for the fourth quarter (ending December 2024) to increase 0.9% year-over-year to $2.31, and its revenue is estimated to increase 5% year-over-year to $22.47 billion for the same quarter. Moreover, the company surpassed the consensus EPS estimates in each of the trailing four quarters.
JNJ's stock has soared 9.7% over the past month and 2.5% over the past six months to close the last trading session at $160.62.
JNJ's growth prospects are reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The stock has an overall rating of A, equating to a Strong Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, each weighted to an optimal degree.
The stock has a B grade for Stability, Quality, and Value. Within the <a href="https://stocknews.com/category/pharmaceuticals/">Medical - Pharmaceuticals</a> industry, JNJ is ranked #14 out of 160 stocks.
<a href="https://stocknews.com/stock/JNJ/">Click here</a> to access additional ratings of JNJ for Growth, Sentiment, and Momentum.
Pfizer Inc. (<a href="https://stocknews.com/stock/PFE/">PFE</a>)
PFE discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers medicines and vaccines in various therapeutic areas like cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and Premarin family brands.
On October 22, PFE received the U.S. FDA approval for its ABRYSVO&#xAE; (Respiratory Syncytial Virus Vaccine), a bivalent RSV prefusion F (RSVpreF) vaccine to prevent lower respiratory tract disease (LRTD) caused by RSV in individuals between 18 and 59 years of age. ABRYSVO offers the broadest indication of the RSV vaccine in adults.
The approval was based on data from the pivotal Phase 3 trial. ABRYSVO is the first and only respiratory syncytial virus vaccine indicated for adults younger than 50. Also, the indication has now been expanded to benefit older adults and pregnant women.
Also, in the same month, PFE received FDA approval for HYMPAVZI&#x2122; (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients 12 years of age and older with hemophilia A. The approval marked a significant advancement for people living with hemophilia A or B without inhibitors for bleed prevention.
During the third quarter that ended September 29, 2024, PFE's total revenues rose 31.2% from the prior-year quarter to $17.70 billion, of which its product revenues grew 33.1% year-over-year to $15.42 billion. The company's adjusted net income and EPS came in at $6.05 billion and $1.06 for the quarter, respectively.
The company had raised its full-year 2024 revenue guidance to a range of $61 billion to $64 billion from the prior range of $59.50 to $62.50 billion. PFE also raised its adjusted EPS guidance to a range of $2.75 to $2.95.
The consensus EPS estimate of $0.46 for the fiscal fourth quarter (ending December 2024) represents a 358% improvement year-over-year. The consensus revenue estimate of $17.36 billion for the ongoing quarter represents a 21.9% increase from last year. The company has an impressive surprise history; it surpassed the consensus EPS estimates in all of the trailing four quarters.
PFE's stock has surged 0.7% over the past six months and 3.9% over the past nine months to close the last trading session at $27.99.
PFE's bright outlook is reflected in its POWR Ratings. It has an overall rating of B, which translates to a Buy in our proprietary rating system.
The stock has an A grade for Growth. It also has a B grade for Value. PFE is ranked #37 among the 160 stocks in the Medical - Pharmaceuticals industry.
<a href="https://stocknews.com/stock/PFE/">Click here</a> to access PFE's other ratings for Quality, Momentum, Stability, and Sentiment.
Genie Energy Ltd. (<a href="https://stocknews.com/stock/GNE/">GNE</a>)
GNE is engaged in the supply of electricity and natural gas to residential and small business customers internationally. The company operates in two segments, GRE and Genie Renewables. It develops, constructs, and operates solar energy projects for commercial and industrial customers.
On March 21, GNE's subsidiary, Sunlight Energy Investments, a retail energy and renewable energy solutions provider, purchased a late-stage solar development project in Hamilton, Indiana, from the project developer. The Hamilton project acquisition fits perfectly with the company's growing portfolio of solar projects, which offers long-term, stable cash flows.
GNE reported total revenue of $90.70 million for the second quarter that ended June 30, 2024, and its income from operations was $10.56 million for the same period. The company's net income attributable to Genie common stockholders and EPS came in at $9.61 million and $0.36 for the quarter, respectively.
Shares of GNE have declined marginally over the past six months to close the last trading session at $15.67.
GNE's POWR Ratings reflect its robust outlook. GNE has an overall B rating, equating to a Buy in our proprietary rating system.
The stock has a B grade for Quality, Sentiment, Momentum, and Value. It is ranked #2 among the 59 stocks in the <a href="https://stocknews.com/category/utilities-domestic/">Utilities - Domestic</a> industry.
<a href="https://stocknews.com/stock/GNE/">Click here</a> to access additional GNE ratings for Stability and Growth.Top of Form
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
JNJ shares were trading at $158.20 per share on Wednesday afternoon, down $0.15 (-0.09%). Year-to-date, JNJ has gained 3.30%, versus a 25.58% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Rjkumari Saxena</h2> <img src='https:/wp-content/uploads/2024/04/Rajkumari-Saxena_Image-1.jpeg' style="float:left; padding:5px;width:125px;">Rajkumari started her career as a writer but gradually shifted her focus to financial journalism, leveraging her educational background in Commerce. Fascinated by the interplay of business and economic shifts in equities, she aspires to evolve as an analyst. With a knack for simplifying complex financial concepts, her mission is to empower investors with insights that lead to profitable decisions.<a href="https://stocknews.com/authors/?author=rajkumari-saxena">More...</a>The post <a href=https://stocknews.com/news/jnj-pfe-gne-3-defensive-stocks-to-buy-as-market-volatility-rises/>3 Defensive Stocks to Buy as Market Volatility Rises</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Defensive Stocks to Buy as Market Volatility Rises

Genie Energy (GNE) has closed on a loan financing on a portfolio of operating solar generation assets. The $7.4 million fixed rate term loan secure...

Genie Energy closes on solar generation project financing

An update from Genie Energy Commo ( ($GNE) ) is now available. Genie Energy Ltd. has secured a $7.4 million fixed-rate loan from National Cooperati...

Genie Energy Secures Loan to Boost Solar Projects

The latest update is out from Genie Energy Commo ( ($GNE) ). Genie Energy has made strides in its consumer insurance initiative by securing broker ...

Genie Energy Expands Insurance Initiatives and Coverage

As electricity demand surges, the world is undergoing a significant shift in energy consumption. The electrification revolution, the rapid expansion of AI-driven data centers, and the growing need for power are driving this rise. For those looking to ride this wave, SSE plc (SSEZY), TransAlta (TAC), and Genie Energy (GNE) stand poised to benefit from the booming sector. Read more… The future is electrifying, quite literally! As artificial intelligence takes off and data centers become more essential than ever, the demand for electricity is skyrocketing. Homes and businesses are also using more power for heating and transportation. This surge is driving a major spike in energy consumption.
Amid this backdrop, investors could scoop up shares of fundamentally stable electric utility stocks, SSE plc (<a href="https://stocknews.com/stock/SSEZY/">SSEZY</a>), TransAlta Corporation (<a href="https://stocknews.com/stock/TAC/">TAC</a>), and Genie Energy Ltd. (<a href="https://stocknews.com/stock/GNE/">GNE</a>). With their stable operations and strong market positions, they offer promising growth potential as the energy landscape evolves.
According to the U.S. Energy Information Administration (EIA), power demand in the United States is forecasted to reach record highs in the coming years. For 2024, EIA projects power demand will <a href="https://www.reuters.com/business/energy/us-power-use-reach-record-highs-2024-2025-eia-forecast-says-2024-12-10/">soar to 4,086 billion kWh</a>, and by 2025, it will climb even further to 4,165 billion kWh.
Residential consumers are leading the charge, with power sales expected to rise to 1,494 billion kWh in 2024. The growing reliance on electricity for everyday needs, from heating to running digital devices, is pushing households to consume more energy.
Commercial customers are not far behind, with power sales forecasted to reach 1,420 billion kWh in 2024. Businesses are increasingly dependent on electricity for everything from lighting to heating, and with the rise of technology and digital services, their energy usage is expected to continue climbing steadily.
Industrial customers are set to use 1,026 billion kWh in 2024. As industries adopt automation, advanced technologies, and sustainable solutions, their electricity needs grow. This shift reflects a broader trend of energy-intensive innovations, driving a surge in industrial electricity consumption.
Looking ahead, rising power demand is set to propel the global electricity distribution utility market to $686.70 billion by 2032, growing at <a href="https://www.gminsights.com/industry-analysis/electric-distribution-utility-market">a 6.7% CAGR</a>, according to a report by Global Market Insights.
So now, let us dive deep into the fundamentals of three electric utility stocks, starting with #3.
Stock #3: SSE plc (<a href="https://stocknews.com/stock/SSEZY/">SSEZY</a>)
Headquartered in Perth, the United Kingdom, SSEZY generates, transmits, distributes, and supplies electricity using water, gas, coal, oil, and multi-fuel resources. The company powers 3.9 million homes and businesses across southern central England and northern Scotland.
On December 6, SSEZY <a href="https://www.sse.com/news-and-views/2024/12/pumped-storage-hydro-critical-to-clean-power/">revealed its Coire Glas project</a>, potentially Britain's largest natural battery, capable of powering three million homes for 24 hours. As the first major pumped storage hydro scheme in 40 years, it would bolster the company's growth, revenue streams, and market competitiveness.
On August 23, a multifuel <a href="https://www.sse.com/news-and-views/2024/08/slough-multifuel-energy-from-waste-facility-begins-operations/">energy-from-waste facility in Slough</a>, co-developed by SSEZY and  Copenhagen Infrastructure Partners (CIP), announced its commencing of operations. By processing 480,000 tonnes of residual waste annually, the facility generates energy for the United Kingdom, contributing to SSEZY's growth.
For the six months that ended September 30, 2024, SSEZY's adjusted operating profit increased 24.1% year-over-year to £860.20 million ($1.10 billion). Its <a href="https://www.investopedia.com/terms/a/adjusted-ebitda.asp">adjusted EBITDA</a> rose 19.2% from the year-ago value to £1.32 billion ($1.69 billion).
Additionally, the company's profit after tax attributable to ordinary shareholders and adjusted EPS grew 35% and 34.6% from the prior year's value to £544.80 million ($694.81 million) and £49.80, respectively.
Analysts expect SSEZY's revenue for the fiscal year ending March 2025 to come in at $13.22 billion. Its EPS for the same period is expected to rise 3.9% year-over-year to $2.10.
Shares of SSEZY have declined 1% intraday, closing the last trading session at $21.17.
SSEZY's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> mirror its sound fundamentals. The stock has an overall rating of B, translating to a Buy in our proprietary rating system. The POWR Ratings are calculated by taking into account 118 different factors, with each factor weighted to an optimal degree.
SSEZY has a B grade for Momentum, Stability, and Value. Within the <a href="https://stocknews.com/category/utilities-foreign/">Utilities - Foreign</a> industry, it is ranked #7 out of 53 stocks.
In addition to the POWR Ratings highlighted above, you can check SSEZY's ratings for Growth, Sentiment, and Quality <a href="https://stocknews.com/stock/SSEZY/">here</a>.
Stock #2: TransAlta Corporation (<a href="https://stocknews.com/stock/TAC/">TAC</a>)
Headquartered in Calgary, Canada, TAC develops, produces and sells electrical energy. The company has five segments: Hydro; Wind and Solar; Gas; Energy Transition; and Energy Marketing. It serves industries like real estate, manufacturing, hospitality, finance, and oil and gas.
On December 4, TAC <a href="https://transalta.com/newsroom/transalta-closes-acquisition-of-heartland-generation/">completed its acquisition</a> of Heartland Generation Ltd. and Alberta Power Ltd. from Energy Capital Partners for an approximate purchase price of $542 million. This acquisition strengthens TAC's portfolio through the company's flexible, fast-ramping capacity and marketing capabilities, as well as by creating meaningful cash flows.
For the fiscal third quarter that ended September 30, 2024, TAC's revenues came in at CAD $638 million ($450.36 million). Its adjusted EBITDA was reported to be CAD $325 million ($229.41 million). Moreover, the company's funds from operations (FFO) and FFO per share came in at CAD $200 million ($141.18 million) and CAD $0.68, respectively.
Street expects TAC's revenue and FFO for the fiscal year ending December 2024 to come in at $2 billion and $1.97, respectively. In addition, the company surpassed the consensus revenue estimates in three of four trailing quarters.
Shares of TAC have surged 46.1% over the past three months and 71.1% over the past year, closing the last trading session at $13.19.
TAC's sound prospects are projected in its POWR Ratings. The stock has an overall rating of B, which equates to a Buy in our proprietary rating system.
TAC has a B grade for Momentum and Quality. Within the Utilities - Foreign industry, it is ranked #16 out of 53 stocks.
<a href="https://stocknews.com/stock/TAC/">Click here</a> to access TAC's ratings for Value, Growth, Sentiment, and Stability.
Stock #1: Genie Energy Ltd. (<a href="https://stocknews.com/stock/GNE/">GNE</a>)
GNE supplies electricity and natural gas to residential and small business customers. The company has two segments: GRE and Genie Renewables. It also develops, constructs, and operates solar energy projects, provides energy brokerage and advisory services and manufactures and distributes solar panels.
On December 5, GNE provided an update on its <a href="https://s3.amazonaws.com/b2icontent.irpass.cc/2100/rl140852.pdf">consumer insurance initiative</a>. The company has secured insurance broker licenses in seven key states and has begun to offer third-party insurance solutions to its customer base. This initiative is in line with the company's risk management strategy, which ensures stable growth.
On November 19, GNE <a href="https://s3.amazonaws.com/b2icontent.irpass.cc/2100/rl140430.pdf">secured $7.4 million</a> in fixed-rate financing from National Cooperative Bank for its 10MW solar array portfolio. Acquired via its Sunlight Energy subsidiary, these arrays supply fixed-price solar power to educational facilities in three Midwestern states, strengthening GNE's renewable energy footprint and financial stability.
For the fiscal 2024 third quarter that ended September 30, GNE's total revenues came in at $111.92 million. Its gross profit and income from operations amounted to $37.91 million and $11.68 million, respectively. Moreover, the company's adjusted EBITDA came in at $15.50 million.
Additionally, non-GAAP net income attributable to GNE common stockholders and non-GAAP EPS were reported to be $10.90 million and $0.41, respectively.
Shares of GNE have surged 1.7% over the past six months to close the last trading session at $14.91.
GNE's robust prospects are apparent in its POWR Ratings. The stock has an overall rating of B, equating to a Buy in our proprietary rating system.
GNE has a B grade for Value, Sentiment, Momentum, and Quality. It has topped the 57-stock <a href="https://stocknews.com/category/utilities-domestic/">Utilities - Domestic</a> industry.
<a href="https://stocknews.com/stock/GNE/">Click here</a> to access its Growth and Stability ratings.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>
<hr />
SSEZY shares were unchanged in premarket trading Thursday. Year-to-date, SSEZY has declined -9.13%, versus a 29.01% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Aanchal Sugandh</h2> <img src='https:/wp-content/uploads/2022/12/Aanchal-Sugandh_Headshot.jpg' style="float:left; padding:5px;width:125px;">Aanchal's passion for financial markets drives her work as an investment analyst and journalist. She earned her bachelor's degree in finance and is pursuing the CFA program.

She is proficient at assessing the long-term prospects of stocks with her fundamental analysis skills. Her goal is to help investors build portfolios with sustainable returns.<a href="https://stocknews.com/authors/?author=aanchal-sugandh">More...</a>The post <a href=https://stocknews.com/news/ssezy-tac-gne-3-high-voltage-electric-utility-stocks-to-plug-into-now/>3 High-Voltage Electric Utility Stocks to Plug Into Now</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 High-Voltage Electric Utility Stocks to Plug Into Now

BIPC

SSEZY

Press Releases

Genie Energy Announces Fourth Quarter and Full Year 2023 Results

Sunlight Energy Investments Acquires an Additional Solar Project

Genie Energy to Report First Quarter 2024 Results

Genie Energy Announces First Quarter 2024 Results

Genie Energy to Report Second Quarter 2024 Results

Genie Energy Announces Second Quarter 2024 Results

Genie Energy to Report Third Quarter 2024 Results

Genie Energy Announces Third Quarter 2024 Results

Financing

Genie Energy Closes on Solar Generation Project Financing

Genie Energy Advances Insurance Strategy

ALLETE

Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor) American Depositary Shares

Empresa Distribuidora y

Companhia Paranaense de Energia (COPEL) American Depositary Shares (each representing one Unit consisting one Common Share and four non-voting Class B Preferred Shares)

Cia Paranaense De Energia

Companhia Paranaense de Energia (COPEL) American Depositary Shares (each representing four (4) Common Shares)

Enel Chile S.A. American Depositary Shares (Each representing 50 shares of Common Stock)

Comments

Genie Energy

Genie Energy (GNE) Forecast

Genie Energy (NYSE:GNE) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga